Trial Profile
A Dose-defining Study of OPC-41061 in Treatment of Hepatic Oedema
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 May 2016
Price :
$35
*
At a glance
- Drugs Tolvaptan (Primary)
- Indications Ascites; Oedema
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Sponsors Otsuka Pharmaceutical
- 19 Apr 2014 New trial record
- 12 Jun 2007